Figure 1.
Morphological features, conventional and molecular cytogenetics, and expression of IL3 in the index case with t(5;7)(q31;q21)/CDK6::IL3. (A and B) Leukemic blasts and eosinophils in the peripheral blood (A) and bone marrow (B) (May-Grunwald Giemsa stain) (Microscope Zeiis, magnification 100×; Camera AXIOCAM 105 color; Software ZEN Imaging Software 2.3); (C) Representative G-banded karyotype of the index case. Arrows indicate chromosomes 5 and 7 involved in reciprocal t(5;7)(q31;q21) (Microscope Olympus BX61, magnification 100×; Camera GENASIS Scanning System, ASI; Software GENASIS Band View, ASI); (D) Double color double fusion FISH experiment on an abnormal metaphase shows two fusion signals on der(5) and der(7), 1 orange signal, on normal chromosome 5, and 1 green signal on normal chromosome 7 (Microscope Olympus BX61, magnification 100×; Camera JAI progressive scan; Software CytoVision [Leica Microsystem]); (E) Schematic representation of DNA clones used for the CDK6::IL3 dual-color fusion assay, and their position relative to CDK6 and IL3. The red arrowhead indicates the position of the CDK6 enhancer; (F) A graph showing the expression levels of IL3 in our cohort of 159 T-ALL cases (RNA microarray data). The red dot corresponds to the index case with the CDK6::IL3 rearrangement; (G) Index case: longitudinal study of IL3 expression levels on samples taken at diagnosis and at different time points during therapy and after HSCT (see also Suppl. Table S1); (H) Validation of RNA microarray data by quantitative RT-PCR: IL3 expression in the index case, at diagnosis (CDK6::IL3) and during treatment (time points TP2 and pre-HSCT), and in 11 ETP-ALL cases without CDK6::IL3 (wt). ASI = applied spectral imaging; ETP-ALL = early T-cell precursor acute lymphoblastic leukemia; HSCT = hematopoietic stem cell transplantation; T-ALL = T-cell acute lymphoblastic leukemia.